-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Stoke Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
- Stoke Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$26.4M, a 7.69% decline year-over-year.
- Stoke Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$105M, a 1.99% decline year-over-year.
- Stoke Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$105M, a 3.59% decline from 2022.
- Stoke Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$101M, a 17.8% decline from 2021.
- Stoke Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$85.8M, a 64.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)